NWL
29
5
EXPE
62
-4
CCI
36
3
PFG
46
-2
PGR
70
5
BRK.B
34
-6
AIG
53
2
BK
66
5
DHR
47
-2
FOX
30
-3
BLK
63
-3
IR
77
2
BWA
38
-2
MPC
44
-5
CRM
64
5
AAL
35
2
AVY
68
-3
PEP
63
22
MMM
33
7
SLB
56
4
NWL
29
5
EXPE
62
-4
CCI
36
3
PFG
46
-2
PGR
70
5
BRK.B
34
-6
AIG
53
2
BK
66
5
DHR
47
-2
FOX
30
-3
BLK
63
-3
IR
77
2
BWA
38
-2
MPC
44
-5
CRM
64
5
AAL
35
2
AVY
68
-3
PEP
63
22
MMM
33
7
SLB
56
4
Financhill
Back

Purple Innovation Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
30

PRPL
Purple Innovation

Last Price:
1.04
Seasonality Move:
-5.66%
Sell
47

RARE
Ultragenyx Pharmaceutical

Last Price:
41.06
Seasonality Move:
-0.9%
Sell
30
Purple Innovation (PRPL) is a Sell

Is Purple Innovation a Buy, Sell or Hold?

  • The current Purple Innovation [PRPL] share price is $1.04. The Score for PRPL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PRPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.42. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRPL Stock Price Chart

What is Purple Innovation's stock price today?

  • The Purple Innovation share price today is $1.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.42
    The current trend is relatively stagnant and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 43.91 Sell
Chaikin Money Flow: 254133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.96 - 1.24) Sell
Bollinger Bands (100): (1.19 - 1.77) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 52.47 Buy
Chaikin Money Flow: 873891 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Buy
Bollinger Bands (100): (40.78 - 48.78) Sell

PRPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.94 Buy
20-day SMA: 1.06 Sell
50-day SMA: 1.32 Sell
200-day SMA: 1.3 Sell
8-day EMA: 0.98 Buy
20-day EMA: 1.07 Sell
50-day EMA: 1.25 Sell
200-day EMA: 1.62 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.5 Buy
20-day SMA: 40.58 Buy
50-day SMA: 41.51 Sell
200-day SMA: 42.46 Sell
8-day EMA: 40.23 Buy
20-day EMA: 40.49 Buy
50-day EMA: 41.77 Sell
200-day EMA: 43.33 Sell

Purple Innovation Earnings Growth & PRPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.26 per share, and an increase next year of $0.25 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Purple Innovation Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):